DH DEFINITIVE HEALTHCARE CORP

Definitive Healthcare to Present at the 2022 Baird Global Healthcare Conference and the 2022 Goldman Sachs Communacopia + Technology Conference

Definitive Healthcare to Present at the 2022 Baird Global Healthcare Conference and the 2022 Goldman Sachs Communacopia + Technology Conference

FRAMINGHAM, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will present at two upcoming conferences: the 2022 Baird Global Healthcare Conference in New York, NY, and the 2022 Goldman Sachs Communacopia + Technology Conference in San Francisco, CA.

  • Chief Executive Officer, Robert Musslewhite, will present at the Baird Conference on Tuesday, September 13, 2022 at 12:15 PM Eastern Time and will be webcast live.

  • Executive Chairman and Founder, Jason Krantz, and Chief Financial Officer, Rick Booth will present at the Goldman Sachs Conference on Wednesday, September 14, 2022 at 5:15 PM Pacific Time (8:15 PM Eastern Time) and will be webcast live.

A live webcast of the presentation will be available on the Events page of the Definitive Healthcare investor relations website at . A replay of the webcast will also be available for a limited time.

About Definitive Healthcare

At Definitive Healthcare, our passion is to transform data, analytics and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities and people, so they can shape tomorrow’s healthcare industry. Our SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next.

Media Contacts:

Danielle Johns

Investor Relations Contact:

Brian Denyeau

ICR for Definitive Healthcare



646-277-1251



EN
06/09/2022

Underlying

DHDEFINITIVE HEALTHCARE CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DEFINITIVE HEALTHCARE CORP

 PRESS RELEASE
Free
DH DEFINITIVE HEAL...

Definitive Healthcare Reports Financial Results for First Quarter Fisc...

Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025 First Quarter Revenue Exceeded Guidance FRAMINGHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2025.  First Quarter 2025 Financial Highlights: Revenue was $59.2 million, a decrease of 7% from $63.5 million in Q1 2024. Net Loss, inclusive of goodwill impairment charges of $176.5 million, was $(155.1) m...

May 8, 2025 1 EN
 PRESS RELEASE
Free
DH DEFINITIVE HEAL...

Definitive Healthcare Announces Timing of Its First Quarter 2025 Finan...

Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast FRAMINGHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its first quarter ended March 31, 2025, on Thursday, May 8, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results. A live audio webcast of the event...

April 24, 2025 1 EN
 PRESS RELEASE
Free
DH DEFINITIVE HEAL...

Definitive Healthcare Corp. reports inducement grants under Nasdaq Lis...

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) FRAMINGHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted inducement awards. The Committee granted Jeff Moyer, Definitive Healthcare’s new SVP of Growth and Sales Operations, an inducement award consisting of 364,...

April 4, 2025 1 EN
 PRESS RELEASE
Free
DH DEFINITIVE HEAL...

Definitive Healthcare Corp. reports inducement grants under Nasdaq Lis...

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) FRAMINGHAM, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of two senior leaders, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted inducement awards. The Committee granted Kate Hastings, Definitive Healthcare’s new Chief Customer Officer an inducement award consisting of 172,414 time-...

March 4, 2025 1 EN
 PRESS RELEASE
Free
DH DEFINITIVE HEAL...

Definitive Healthcare Reports Financial Results for Fourth Quarter and...

Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024 Fourth quarter and full year 2024 revenue exceeded guidance FRAMINGHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and full year ended December 31, 2024.  Fourth Quarter 2024 Financial Highlights: Revenue was $62.3 million, a decrease of 6% from $65.9 million in Q4 2023. Net Loss, inclusive of goodwill imp...

February 27, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch